Can they run a business?, page-129

Hey cunjevoi,

IMU now seems to be a conundrum with its three platforms and many spin off drugs from each platform!

I can see how it is now a complete headf*#k for new investors to understand and follow all three platforms, along with each drugs in the different platforms!!

"TB - get my facts correct?" - IMHO @Taureanbull was actually trying to help you!!!

Anyway let's get back to your question!!!! - "For example she says in that interview posted below that CF33 'expresses' CD19 (it doesn't and it cant - it's a virus - a virus needs a host cell for gene expression)" - But this is not what LC was referring to, LC was talking about a different onCARlytics which is a different platform!!!!

This may explain onCARlytics a little better (especially at the 2.30 minute mark where Dr. Saul Priceman states that they "re-engineered the virus to express CD19" -



Dr. Jakop Dupont also sheds some light at the 18.50 minute mark on what IMU are doing with expressing CD19 onto tumours -



If the above doesn't make any sense - Then the image below will!!!!!





Hope the above helps!!!!!!!!!!!!!!!!!!!!!!!!!!!!!

Cheers,
AC